Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
KYORIN Pharmaceutical Co.,Ltd. ( (JP:4569) ) has issued an announcement.
KYORIN Pharmaceutical Co., Ltd. reported significant growth in its financial performance for the three months ended June 30, 2025, with net sales increasing by 6.4% and operating profit surging by 106% compared to the same period last year. Despite the positive quarterly results, the company forecasts a decline in full-year profits, indicating potential challenges ahead.
More about KYORIN Pharmaceutical Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd. is a company operating in the pharmaceutical industry, focusing on the development and sale of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is led by President and CEO Yutaka Ogihara.
Average Trading Volume: 97,425
Technical Sentiment Signal: Hold
Current Market Cap: Yen80.28B
For detailed information about 4569 stock, go to TipRanks’ Stock Analysis page.